Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons

Neuroscience

Volumn 98, Issue 3, 2000, Pages 585-598

  Honore, P ^a,b   Rogers, S D ^a,b   Schwei, M J ^a,b   Salak Johnson, J L ^a,b   Luger, N M ^a,b   Sabino, M C ^a,b   Clohisy, D R ^c   Mantyh, P W ^a,b  

^a Neurosystems Center   (United States)

^b VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Astrocyte hypertrophy; Bone; c Fos protein; Dynorphin; Osteolysis; Persistent pain

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DYNORPHIN; GALANIN; NEUROPEPTIDE Y; NEUROTRANSMITTER; PROTEIN C FOS; PROTEIN KINASE C; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CANCER PAIN; CONTROLLED STUDY; HISTOPATHOLOGY; HORMONE RESPONSE; HYPERALGESIA; HYPERTROPHY; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; OSTEOSARCOMA; PAW EDEMA; PRIORITY JOURNAL; SENSORY NEUROPATHY; SPINAL CORD TRANSSECTION;

ANIMALS; ASTROCYTES; AXOTOMY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DYNORPHINS; FLUORESCENT ANTIBODY TECHNIQUE; FREUND'S ADJUVANT; GANGLIA, SPINAL; MALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEURALGIA; NEURITIS; NEURONS, AFFERENT; OSTEOLYSIS; PAIN; PALPATION; PHYSICAL STIMULATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, NEUROKININ-1; SARCOMA, EXPERIMENTAL; SCIATIC NERVE; SPINAL CORD; SPINAL NERVES; TUMOR CELLS, CULTURED;

EID: 0034130227     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00110-X     Document Type: Article

References (96)

1. Abbadie C., Brown J.L., Mantyh P.W., Basbaum A.I. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience. 70:1996;201-209.
2. Abbadie C., Honore P., Fourniezaluski M.C., Roques B.P., Besson J.-M. Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation. Eur. J. Pharmac. 258:1994;215-227.
3. Abbadie C., Trafton J., Liu H., Mantyh P.W., Basbaum A.I. Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J. Neurosci. 17:1997;8049-8060.
4. Adami S. Bisphosphonates in prostate carcinoma. Cancer. 80:1997;1674-1679.
5. Ahmed M., Bjurholm A., Schultzberg M., Theodorsson E., Kreicbergs A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arth. Rheum. 38:1995;699-709.
6. Allen B.J., Rogers S.D., Ghilardi J.R., Menning P.M., Kuskowski M.A., Basbaum A.I., Simone D.A., Mantyh P.W. Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J. Neurosci. 17:1997;5921-5927.
7. Ambalavanar R., Morris R. The distribution of binding by isolectin I-B4 from Griffonia simplicifolia in the trigeminal ganglion and brainstem trigeminal nuclei in the rat. Neuroscience. 47:1992;421-429.
8. Attal N., Brasseur L., Parker F., Chauvin M., Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur. Neurol. 40:1998;191-200.
9. Barber P.C., Dahl D. Glial fibrillary acidic protein (GFAP)-like immunoreactivity in normal and transected rat olfactory nerve. Expl Brain Res. 65:1987;681-685.
10. Basbaum A.I. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med. 24:1999;59-67.
11. Belknap J.K., Lame M., Danielson P.W. Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment. Behav. Genet. 20:1990;333-338.
12. Belknap J.K., Noordewier B., Lame M. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol. Behav. 46:1989;69-74.
13. Belknap J.K., Riggan J., Cross S., Young E.R., Gallaher E.J., Crabbe J.C. Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmac. Biochem. Behav. 59:1998;353-360.
14. Bergman E., Carlsson K., Liljeborg A., Manders E., Hokfelt T., Ulfhake B. Neuropeptides, nitric oxide synthase and GAP-43 in B4-binding and RT97 immunoreactive primary sensory neurons: normal distribution pattern and changes after peripheral nerve transection and aging. Brain Res. 832:1999;63-83.
15. Bleazard L., Hill R.G., Morris R. The correlation between the distribution of the NK1 receptor and the actions of tachykinin agonists in the dorsal horn of the rat indicates that substance P does not have a functional role on substantia gelatinosa (lamina II) neurons. J. Neurosci. 14:1994;7655-7664.
16. Calza L., Pozza M., Zanni M., Manzini C.U., Manzini E., Hokfelt T. Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience. 82:1998;575-589.
17. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J.H., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-394.
18. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Meth. 53:1994;55-63.
19. Clohisy D.R., Ogilvie C.M., Carpenter R.J., Ramnaraine M.L. Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts. J. Ortho. Res. 14:1996;2-6.
20. Clohisy D.R., Ogilvie C.M., Ramnaraine M.L. Tumor osteolysis in osteopetrotic mice. J. Ortho. Res. 13:1995;892-897.
21. Coggeshall R.E., Reynolds M.L., Woolf C.J. Distribution of the growth associated protein GAP-43 in the central processes of axotomized primary afferents in the adult rat spinal cord; presence of growth cone-like structures. Neurosci. Lett. 131:1991;37-41.
22. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J. Neuroimmunol. 79:1997;163-175.
23. Colburn R.W., Rickman A.J., DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Expl Neurol. 157:1999;289-304.
24. Curtis R., Averill S., Priestley J.V., Wilkin G.P. The distribution of GAP-43 in normal rat spinal cord. J. Neurocytol. 22:1993;39-50.
25. Defelipe C., Herrero J.F., Obrien J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
26. Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 49:1992;693-698.
27. Doyle C.A., Hunt S.P. Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: a c-Fos study in rat. Neuroscience. 89:1999;17-28.
28. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
29. Elmer G.I., Pieper J.O., Negus S.S., Woods J.H. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75:1998;129-140.
30. Eriksson N.P., Persson J.K., Svensson M., Arvidsson J., Molander C., Aldskogius H. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Expl Brain Res. 96:1993;19-27.
31. Field M.J., McCleary S., Hughes J., Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 80:1999;391-398.
32. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmac. 121:1997;1513-1522.
33. Fields H.L. Can opiates relieve neuropathic pain? Pain. 35:1988;365-367.
34. Fields H.L. Pain modulation: opiates and chronic pain. NIDA Res. Monograph. 95:1989;92-101.
35. Fitzgerald M. c-Fos and the changing face of pain. Trends Neurosci. 13:1990;439-440.
36. Fitzgerald M., Wall P.D., Goedert M., Emson P.C. Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve section. Brain Res. 332:1985;131-141.
37. Galeazza M.T., Garry M.G., Yost H.J., Strait K.A., Hargreaves K.M., Seybold V.S. Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience. 66:1995;443-458.
38. Garrison C.J., Dougherty P.M., Carlton S.M. Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats. Brain Res. 607:1993;205-214.
39. Garrison C.J., Dougherty P.M., Kajander K.C., Carlton S.M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 565:1991;1-7.
40. Gonzalez-Hernandez T., Rustioni A. Nitric oxide synthase and growth associated protein are co-expressed in primary sensory neurons after peripheral injury. J. comp. Neurol. 404:1999;64-74.
41. Hanesch U., Blecher F., Stiller R.U., Emson P.C., Schaible H.G., Heppelmann B. The effect of a unilateral inflammation at the rat's ankle joint on the expression of preprotachykinin-A mRNA and preprosomatostatin mRNA in dorsal root ganglion cells - a study using non-radioactive in situ hybridization. Brain Res. 700:1995;279-284.
42. Hanesch U., Pfrommer U., Grubb B.D., Schaible H.G. Acute and chronic phases of unilateral inflammation in rat's ankle are associated with an increase in the proportion of calcitonin gene-related peptide-immunoreactive dorsal root ganglion cells. Eur. J. Neurosci. 5:1993;154-161.
43. Herdegen T., Fiallos-Estrada C., Schmid W., Bravo R., Zimmermann M. The transcription factor CREB, but not immediate-early gene encoded proteins, is expressed in activated microglia of lumbar spinal cord following sciatic nerve transection in the rat. Neurosci. Lett. 142:1992;57-61.
44. Hokfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17:1994;22-30.
45. Honore P., Buritova J., Besson J.M. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord - the effects of indomethacin. Eur. J. Pharmac. 272:1995;249-259.
46. Honore P., Buritova J., Fournie-Zaluski M.C., Roques B.P., Besson J.M. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. J. Pharmac. exp. Ther. 281:1997;208-217.
47. Honore P., Chapman V., Buritova J., Besson J.M. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a Mu opioid agonist influence noxiously evoked c-Fos expression in the rat - a pharmacological study. J. Pharmac. exp. Ther. 278:1996;393-403.
48. Honore P., Menning P.M., Rogers S.D., Nichols M.L., Basbaum A.I., Besson J.-M., Mantyh P.W. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J. Neurosci. 19:1999;7670-7678.
49. Hunt S.P., Pini A., Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;632-634.
50. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmac. 324:1997;153-160.
51. Huvos A.G. Bone tumors - Diagnosis, treatment, and prognosis. 2nd :1991;W.B. Saunders Company, Philadelphia.
52. Hylden J.L., Noguchi K., Ruda M.A. Neonatal capsaicin treatment attenuates spinal Fos activation and dynorphin gene expression following peripheral tissue inflammation and hyperalgesia. J. Neurosci. 12:1992;1716-1725.
53. Ji R.R., Zhang X., Wiesenfeld-Hallin Z., Hokfelt T. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J. Neurosci. 14:1994;6423-6434.
54. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
55. Kuraishi Y., Nanayama T., Ohno H., Fujii N., Otaka A., Yajima H., Satoh M. Calcitonin gene-related peptide increases in the dorsal root ganglia of adjuvant arthritic rat. Peptides. 10:1989;447-452.
56. LaMotte C., Kapadia S.E., Shapiro C.M. Central projections of the sciatic, saphenous, median, and ulnar nerves of the rat demonstrated by transganglionic transport of choleragenoid-HRP (B-HRP) and wheat germ agglutinin-HRP (WGA-HRP). J. comp. Neurol. 311:1991;546-562.
57. Lanteri-Minet M., de Pommery J., Herdegen T., Weil-Fugazza J., Bravo R., Menetrey D. Differential time-course and spatial expression of Fos, Jun, and Krox-24 proteins in spinal cord of rats undergoing subacute or chronic somatic inflammation. J. comp. Neurol. 333:1993;223-235.
58. Linda H., Piehl F., Dagerlind A., Verge V.M., Arvidsson U., Cullheim S., Risling M., Ulfhake B., Hokfelt T. Expression of GAP-43 mRNA in the adult mammalian spinal cord under normal conditions and after different types of lesions, with special reference to motorneurons. Expl Brain Res. 91:1992;284-295.
59. Malmberg A.B., Brandon E.P., Idzerda R.L., Liu H., McKnight G.S., Basbaum A.I. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory sub-unit of cAMP-dependent protein kinase. J. Neurosci. 17:1997;7462-7470.
60. Mantyh P.W., Allen C.J., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc. natn. Acad. Sci. U.S.A. 92:1995;2622-2626.
61. Mantyh P.W., DeMaster E., Malhotra A., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E., Simone D.A. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science. 268:1995;1629-1632.
62. Mantyh P.W., Rogers S.D., Honore P., Allen B.J., Ghilardi J.R., Li J., Daughters R.S., Lappi D.A., Wiley R.G., Simone D.A. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science. 278:1997;275-279.
63. Marsh D., Dickenson A., Hatch D., Fitzgerald M. Epidural opioid analgesia in infant rats II: responses to carrageenan and capsaicin. Pain. 82:1999;33-38.
64. Martin W.J., Liu H., Wang H., Malmberg A.B., Basbaum A.I. Inflammation-induced up-regulation of protein kinase C-gamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience. 88:1999;1267-1274.
65. Maycox P.R., Link E., Reetz A., Morris S.A., Jahn R. Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling. J.Cell Biol. 118:1992;1379-1388.
66. Mercadante S., Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat. Rev. 24:1998;425-432.
67. Mogil J.S., Adhikari S.M. Hot and cold nociception are genetically correlated. J. Neurosci. 19:1999;13-17.
68. Mogil J.S., Flodman P., Spence M.A., Sternberg W.F., Kest B., Sadowski B., Liebeskind J.C., Belknap J.K. Oligogenic determination of morphine analgesic magnitude: a genetic analysis of selectively bred mouse lines. Behav. Genet. 25:1995;397-406.
69. Mogil J.S., Kest B., Sadowski B., Belknap J.K. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception - influence of nociceptive assay. J. Pharmac. exp. Ther. 276:1996;532-544.
70. Mogil J.S., Richards S.P., Otoole L.A., Helms M.L., Mitchell S.R., Belknap J.K. Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains - possible sex-specific mediation by delta 2-opioid receptors. Pain. 70:1997;267-277.
71. Mogil J.S., Wilson S.G., Bon K., Lee S.E., Chung K., Raber P., Pieper J.O., Hain H.S., Belknap J.K., Hubert L., Elmer G.I., Chung J.M., Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain. 80:1999;67-82.
72. Molander C., Grant G. Cutaneous projection from the rat hindlimb foot to substantia gelatinosa of the spinal cord studied by transganglionic transport of WGA-HRP conjugate. J. comp. Neurol. 237:1985;476-484.
73. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat: I. The lower thoracic and lumbosacral cord. J. comp. Neurol. 230:1984;133-141.
74. Nahin R.L., Hylden J.L., Iadarola M.J., Dubner R. Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci. Lett. 96:1989;247-252.
75. Nahin R.L., Ren K., De Leon M., Ruda M. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain. 58:1994;95-108.
76. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are co-localized in spinal cord neurons. Molec. Brain Res. 10:1991;227-233.
77. Noguchi K., Senba E., Morita Y., Sato M., Tohyama M. Prepro-VIP and preprotachykinin mRNAs in the rat dorsal root ganglion cells following peripheral axotomy. Molec. Brain Res. 6:1989;327-330.
78. Ossipov M.H., Kovelowski C.J., Porreca F. The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective delta-opioid antagonist. Neurosci. Lett. 184:1995;173-176.
79. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199:1995;87-90.
80. Pan H.L., Eisenach J.C., Chen S.R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J. Pharmac. exp. Ther. 288:1999;1026-1030.
81. Portenoy R.K. Pharmacologic management of cancer pain. Seminars Oncol. 22:1995;112-120.
82. Portenoy R.K., Lesage P. Management of cancer pain. Lancet. 353:1999;1695-1700.
83. Portenoy R.K., Payne D., Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 81:1999;129-134.
84. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmac. 115:1995;1265-1275.
85. Schwei M.J., Honore P., Rogers S.D., Johnson J.L., Finke M.P., Rarmaraine M., Clohisy D.R., Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J. Neurosci. 19:1999;10,886-10,897.
86. Smith G.D., Harmar A.J., McQueen D.S., Seckl J.R. Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant mono-arthritis in the rat. Neurosci. Lett. 137:1992;257-260.
87. Solodkin A., Traub R.J., Gebhart G.F. Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase histochemical staining in the rat lumbar spinal cord. Neuroscience. 51:1992;495-499.
88. Stuart G.J., Davey E.B., Wight S.E. Continuous intravenous morphine infusions for terminal pain control: a retrospective review. Drug Intel. clin. Pharm. 20:1986;968-972.
89. Unni K.K. Dahlin's bone tumors - General aspects and data on 11,087 cases. Fifth :1996;Lippincott-Raven, Philadelphia.
90. Villar M.J., Wiesenfeld-Hallin Z., Xu X.J., Theodorsson E., Emson P.C., Hokfelt T. Further studies on galanin-, substance P-, and CGRP-like immunoreactivities in primary sensory neurons and spinal cord: effects of dorsal rhizotomies and sciatic nerve lesions. Expl Neurol. 112:1991;29-39.
91. Wakisaka S., Kajander K.C., Bennett G.J. Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res. 598:1992;349-352.
92. Warfield C.A. Controlled-release morphine tablets in patients with chronic cancer pain: a narrative review of controlled clinical trials. Cancer. 82:1998;2299-2306.
93. Weihe E., Millan M.J., Hollt V., Nohr D., Herz A. Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats. Neuroscience. 31:1989;77-95.
94. Weihe E., Nohr D., Millan M.J., Stein C., Muller S., Gramsch C., Herz A. Peptide neuro-anatomy of adjuvant-induced arthritic inflammation in rat. Agents Actions. 25:1988;255-259.
95. Zhang X., Bean A.J., Wiesenfeld-Hallin Z., Hokfelt T. Ultrastructural studies on peptides in the dorsal horn of the rat spinal cord-IV. Effects of peripheral axotomy with special reference to neuropeptide Y and vasoactive intestinal polypeptide/peptide histidine isoleucine. Neuroscience. 64:1995;917-941.
96. Zhang X., Bean A.J., Wiesenfeld-Hallin Z., Xu X.J., Hokfelt T. Ultrastructural studies on peptides in the dorsal horn of the rat spinal cord-III. Effects of peripheral axotomy with special reference to galanin. Neuroscience. 64:1995;893-915.